{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:11:40Z","timestamp":1793045500483,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The exact characteristics of primary ovarian carcinoid tumors remain largely unknown because of the rarity of the cases. This study aimed to investigate the clinical features, pathological characteristics, and therapeutic outcomes of patients with primary ovarian carcinoid tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective case series included patients with primary ovarian carcinoid tumors diagnosed between January 2009 and December 2023 at the First Affiliated Hospital of Wenzhou Medical University.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Fifteen patients were included. They were 45.8\u2009\u00b1\u20092.7 years at diagnosis. Eight tumors were located in the left ovary, while seven were in the right. All patients were stage I. Microscopically, nine tumors were classified as strumal carcinoid, two as insular carcinoid, three as trabecular carcinoid, and one as mixed. Synaptophysin (Syn) was positive in 14 cases, chromogranin A (CgA) in 10, CD56 in eight, thyroid transcription factor 1 (TTF-1) in five, and thyroglobulin (TG) in six. Twelve patients had a Ki67 index\u2009\u2264\u20097%. All 15 patients underwent surgery, with eight retaining fertility. Among them, one patient underwent comprehensive staging surgery, four underwent lateral adnexectomy, and three underwent cyst stripping. Seven patients underwent total hysterectomy and bilateral adnexectomy, including two patients undergoing comprehensive staging surgery. Three patients received intravenous chemotherapy. One patient was lost to follow-up. The remaining patients were followed up for 48\u2013148 months; they were without recurrences and alive at the last follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Primary ovarian carcinoid tumors present with atypical symptoms and signs. Surgical intervention may be an optimal choice for treatment, leading to favorable prognostic outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12957-025-03731-3","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:51:20Z","timestamp":1741686680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical, pathological characteristics, and therapeutic outcomes of primary ovarian carcinoid tumors: a case series of 15 cases"],"prefix":"10.1186","volume":"23","author":[{"given":"Xinyue","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suidan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"3731_CR1","doi-asserted-by":"publisher","first-page":"e9415","DOI":"10.1097\/MD.0000000000009415","volume":"97","author":"R Linhas","year":"2018","unstructured":"Linhas R, Tente D, China N, Conde S, Barroso A. Subcutaneous metastasis of a pulmonary carcinoid tumor: A case report. Med (Baltim). 2018;97:e9415.","journal-title":"Med (Baltim)"},{"key":"3731_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united States. JAMA Oncol. 2017;3:1335\u201342.","journal-title":"JAMA Oncol"},{"key":"3731_CR3","doi-asserted-by":"crossref","unstructured":"Virarkar M, Vulasala SS, Morani AC et al. Neuroendocrine neoplasms of the gynecologic tract. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14071835"},{"key":"3731_CR4","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/1097-0142(19801101)46:9<2019::AID-CNCR2820460921>3.0.CO;2-W","volume":"46","author":"SJ Robboy","year":"1980","unstructured":"Robboy SJ, Scully RE. Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer. 1980;46:2019\u201334.","journal-title":"Cancer"},{"key":"3731_CR5","unstructured":"WHO Classification of Tumours Editorial Board. WHO classification of tumours: female genital tumours. IARC; 2020."},{"key":"3731_CR6","doi-asserted-by":"publisher","first-page":"e21109","DOI":"10.1097\/MD.0000000000021109","volume":"99","author":"LR Zhai","year":"2020","unstructured":"Zhai LR, Zhang XW, Yu T, et al. Primary ovarian carcinoid: two cases report and review of literature. Med (Baltim). 2020;99:e21109.","journal-title":"Med (Baltim)"},{"key":"3731_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/PGP.0000000000000675","volume":"40","author":"TS Halvorson","year":"2021","unstructured":"Halvorson TS, Robinson RA, Samuelson MI. Pure primary ovarian carcinoid tumor. Int J Gynecol Pathol. 2021;40:301\u20134.","journal-title":"Int J Gynecol Pathol"},{"key":"3731_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3889\/oamjms.2018.138","volume":"6","author":"VS Antovska","year":"2018","unstructured":"Antovska VS, Trajanova M, Krstevska I, et al. Ovarian strumal carcinoid tumour: case report. Open Access Maced J Med Sci. 2018;6:540\u20133.","journal-title":"Open Access Maced J Med Sci"},{"key":"3731_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/aogs.14578","volume":"102","author":"S Kong","year":"2023","unstructured":"Kong S, Sun J, Sui X, et al. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study. Acta Obstet Gynecol Scand. 2023;102:935\u201341.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3731_CR10","doi-asserted-by":"crossref","unstructured":"Shen LP, Yang AQ, Jin L. Strumal carcinoid tumor of the ovary: report of rare occurrence with review of literature. Diagnostics (Basel). 2022;12.","DOI":"10.3390\/diagnostics12112706"},{"key":"3731_CR11","doi-asserted-by":"publisher","first-page":"871210","DOI":"10.3389\/fendo.2022.871210","volume":"13","author":"A Turla","year":"2022","unstructured":"Turla A, Zamparini M, Milione M, et al. Ovarian strumal carcinoid: case report, systematic literature review and pooled analysis. Front Endocrinol (Lausanne). 2022;13:871210.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3731_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3731_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ygyno.2020.01.002","volume":"157","author":"D Nasioudis","year":"2020","unstructured":"Nasioudis D, Frey MK, Chapman-Davis E, Caputo TA, Holcomb K. Primary malignant ovarian carcinoid; management and outcomes. Gynecol Oncol. 2020;157:101\u20135.","journal-title":"Gynecol Oncol"},{"key":"3731_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jnci.2016.06.003","volume":"28","author":"IH Metwally","year":"2016","unstructured":"Metwally IH, Elalfy AF, Awny S, Elzahaby IA, Abdelghani RM. Primary ovarian carcinoid: A report of two cases and a decade registry. J Egypt Natl Canc Inst. 2016;28:267\u201375.","journal-title":"J Egypt Natl Canc Inst"},{"key":"3731_CR15","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.4081\/rt.2010.e39","volume":"2","author":"CC Buis","year":"2010","unstructured":"Buis CC, van Doorn HC, Dinjens WN, Ewing PC. Mucinous carcinoid of the ovary: report of a case with metastasis in the contralateral ovary after ten years. Rare Tumors. 2010;2:e39.","journal-title":"Rare Tumors"},{"key":"3731_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4132\/jptm.2015.09.20","volume":"49","author":"YK Chun","year":"2015","unstructured":"Chun YK. Neuroendocrine tumors of the female reproductive tract: A literature review. J Pathol Transl Med. 2015;49:450\u201361.","journal-title":"J Pathol Transl Med"},{"key":"3731_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/1097-0142(19930901)72:5<1673::AID-CNCR2820720530>3.0.CO;2-G","volume":"72","author":"J Sidhu","year":"1993","unstructured":"Sidhu J, S\u00e1nchez RL. Prostatic acid phosphatase in strumal carcinoids of the ovary. An immunohistochemical study. Cancer. 1993;72:1673\u20138.","journal-title":"Cancer"},{"key":"3731_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12905-022-01660-x","volume":"22","author":"W Zhang","year":"2022","unstructured":"Zhang W, Chen Q. Primary ovarian carcinoid arising in associated mature cystic teratoma. BMC Womens Health. 2022;22:76.","journal-title":"BMC Womens Health"},{"key":"3731_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/PGP.0000000000000393","volume":"37","author":"D Niu","year":"2018","unstructured":"Niu D, Li Z, Sun L, Cao D. Carcinoid arising from the teratomatous bronchial mucosa in a mature cystic teratoma of the ovary: A case report. Int J Gynecol Pathol. 2018;37:123\u20137.","journal-title":"Int J Gynecol Pathol"},{"key":"3731_CR20","first-page":"517","volume":"47","author":"HJ Ge","year":"2018","unstructured":"Ge HJ, Bi R, Cheng YF, et al. [Clinicopathologic analysis of primary carcinoid of the ovary]. Zhonghua Bing Li Xue Za Zhi. 2018;47:517\u201321.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"3731_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2018.05.003","volume":"430","author":"T Wang","year":"2018","unstructured":"Wang T, Wu H, Liu S, et al. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance. Cancer Lett. 2018;430:11\u201324.","journal-title":"Cancer Lett"},{"key":"3731_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/gye.17.1.1.6","volume":"17","author":"M Resl","year":"2003","unstructured":"Resl M, Reslov\u00e1 T, Krejc\u00ed E, et al. Proliferative activity in primary ovarian carcinoid tumors. Gynecol Endocrinol. 2003;17:1\u20136.","journal-title":"Gynecol Endocrinol"},{"key":"3731_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/01.pas.0000213355.72638.f4","volume":"31","author":"C Zhao","year":"2007","unstructured":"Zhao C, Bratthauer GL, Barner R, Vang R. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian Sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases. Am J Surg Pathol. 2007;31:255\u201366.","journal-title":"Am J Surg Pathol"},{"key":"3731_CR24","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/IGC.0000000000000265","volume":"24","author":"NS Reed","year":"2014","unstructured":"Reed NS, Gomez-Garcia E, Gallardo-Rincon D, et al. Gynecologic Cancer intergroup (GCIG) consensus review for carcinoid tumors of the ovary. Int J Gynecol Cancer. 2014;24:S35\u201341.","journal-title":"Int J Gynecol Cancer"},{"key":"3731_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tjog.2019.05.025","volume":"58","author":"WW Hsu","year":"2019","unstructured":"Hsu WW, Mao TL, Chen CH. Primary ovarian mucinous carcinoid tumor: A case report and review of literature. Taiwan J Obstet Gynecol. 2019;58:570\u20133.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"3731_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ajo.12503","volume":"56","author":"S McGrath","year":"2016","unstructured":"McGrath S, Nicklin J. Clinicopathological study of ovarian carcinoid tumours. Aust N Z J Obstet Gynaecol. 2016;56:508\u201313.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"3731_CR27","unstructured":"NCCN Clinical Practice Guidelines in oncology (NCCN Guidelines). Ovarian cancer, including fallopian tube Cancer and primary peritoneal Cancer. Version 1.2024. National Comprehensive Cancer Network.; 2024."},{"key":"3731_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/IGC.0000000000001215","volume":"28","author":"VA Preda","year":"2018","unstructured":"Preda VA, Chitoni M, Talbot D, Reed N, Grossman AB. Primary ovarian carcinoid: extensive clinical experience with an underrecognized uncommon entity. Int J Gynecol Cancer. 2018;28:466\u201371.","journal-title":"Int J Gynecol Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03731-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03731-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03731-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T10:42:13Z","timestamp":1741862533000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03731-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3731"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03731-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association. This study was approved by the Ethics Committee in Clinical Research of the First Affiliated Hospital of Wenzhou Medical University (KY2023-R234), and all participants provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}